Climate change and global warming resulting from greenhouse gas emissions are widely recognized as the biggest threats to global health. The healthcare sector is responsible for 4–5% of global emissions, more than 70% of which are driven by supply chains.
Supply Chain to Patient
Viewing related articles
CGT Viral clearance validation aspects
Oct 2022 | Benchmarking, Cell & Gene Therapy, Deliverable, Deliverables Report, Supply Chain to Patient, Validation
A BioPhorum member only survey to understand viral purification and clearance practices member companies are undertaking in CGT.
Logistic service provider (LSP) integration
Sep 2019 | Deliverable, Information Technology, POI - Supply Chain to Patient, Publication, Supply Chain to Patient
Many biomanufacturers use a network of logistics service providers (LSPs) to deliver warehousing, transport and distribution services. Typically linked using customized, electronic, point-to-point connections. These connections can be expensive and slow to set-up and expensive to update in response to changing market demands. There is no dominant technical solution that monitors the condition and location of shipments, and that enables companies to adopt different solutions for different regions and partners. There is a need to raise the awareness of software vendors of this unmet need and the real interest of many industry stakeholders if a suitable LSP integration solution was available.
This paper provides an overview of the current needs of manufacturers and their technical integration with their network of LSPs. It contains a high-level requirements specification for a common, cloud-based, integration platform, that would reduce customization and multiple point-to-point solutions. The specification is designed to help technology companies develop this services. Informal benchmarking across member companies indicates that ‘collaboration hub’ use would deliver a 50–70% saving in time and cost when linking to a new partner. These benefits would be realized by both partners making the new connection.
Transport: Best practice on transport qualification: good distribution practice
Jul 2019 | Drug Substance, POI - Supply Chain to Patient, Publication, Supply Chain to Patient
Shipping lane validation or qualification of thermal protection systems is not a simple task. Each pharmaceutical company and regulatory body use different standards leading to inconsistency. Vendors also do not have a standard for the specific tests that customers require. This absorbs huge amounts of resources for qualification testing, where work is unnecessarily repeated and existing data is not leveraged. To address this, the guidance details a best practice for standardized shipping lane validation that can deliver an annual saving of between $0.5m and $1m per shipping solution, a 50% reduction in resource requirements, and a reduction in product submission timelines by as much as 6-12 months.